For other salt forms please inquire. Polymer-linked dimeric (PLD) cGMP analogue in which two cGMP units are linked by a polydisperse 2000 Dalton spacer on basis of polyethylene glycol (PEG) via thioethers at the C8 positions.
Membrane-permeant cGMP dimer with enhanced PKG activation properties by addressing two binding sites simultaneously with a single molecule.
Activation constants of cGMP-8-TMAmd-(PEG pd 2000)-AmdMT-8-cGMP in vitro on purified cGMP-dependent protein kinase (PKG) isozymes were measured to be in the range of 7.7 ± 1.3 nM (PKG1α), 21 ± 2 nM (PKG1β), and 2.1 ± 0.6 nM (PKG2), respectively. The compound significantly reduced proliferation, migration and increased cell death in two melanoma cell lines (all data according to Vighi et al. 2017). In the colon cancer cell lines Caco-2 and HCT 116, treatment with cGMP-8-TMAmd-(PEG pd 2000)-AmdMT-8-cGMP led to a significant reduction of cell viability (Hoffmann et al. 2017). References: Vighi et al., Oncotarget, 9, 5301-5320 (2017); Hoffmann et al., Eur. J. Med. Chem., 141, 61-72 (2017).
Cat. No. | G 043 |
CAS number | [pending] |
Purity | > 95% HPLC (est.) |
Salt form | Disodium |
Storage temperature | -20°C / -4°F |
Modifications | 8-cGMP |
Target | PKG (cGK) Activator |
Absorption max [nm] | 275 |
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] | 24660 |
UV pH value | 7 |